ALEX MANDL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALEX MANDL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALEX MANDL. ALEX MANDL is Director in Genpact LTD ($G) and Director in Accretive Health, Inc. ($AH).
Latest Insider Trading Transactions of ALEX MANDL
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2021 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 0.00 | 5,151 | 0 | 17,245 | |
| Oct 02 2020 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 17.54 | 3,643 | 63,898 | 3,643 | |
| Jun 15 2020 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | M | 0.00 | 11,207 | 0 | 12,094 | |
| Jun 15 2020 | AH | R1 RCM INC. | MANDL ALEX | Director | Buy | M | 0.00 | 11,207 | 0 | 268,871 | 257.7 K to 268.9 K (+4.35 %) |
| May 29 2020 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 0.00 | 12,094 | 0 | 23,301 | |
| Apr 03 2020 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 8.41 | 7,569 | 63,655 | 7,569 | |
| Apr 03 2020 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 8.41 | 7,569 | 63,655 | 7,569 | |
| Oct 03 2019 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 9.05 | 6,708 | 60,707 | 6,708 | |
| Jul 02 2019 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 12.65 | 4,743 | 59,999 | 4,743 | |
| Jun 18 2019 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 0.00 | 11,207 | 0 | 11,207 | |
| Jun 04 2019 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | M | 0.00 | 16,394 | 0 | 0 | |
| Jun 04 2019 | AH | R1 RCM INC. | MANDL ALEX | Director | Buy | M | 0.00 | 16,394 | 0 | 257,664 | 241.3 K to 257.7 K (+6.79 %) |
| Apr 02 2019 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 9.57 | 6,140 | 58,760 | 6,140 | |
| Jan 03 2019 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 7.89 | 7,141 | 56,342 | 7,141 | |
| Dec 20 2018 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 8.13 | 2,756 | 22,406 | 2,756 | |
| Oct 03 2018 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 10.01 | 4,425 | 44,294 | 4,425 | |
| Sep 18 2018 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | M | 0.00 | 41,270 | 0 | 0 | |
| Sep 18 2018 | AH | R1 RCM INC. | MANDL ALEX | Director | Buy | M | 0.00 | 41,270 | 0 | 241,270 | 200 K to 241.3 K (+20.64 %) |
| Jul 03 2018 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 8.65 | 5,162 | 44,651 | 5,162 | |
| May 31 2018 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 0.00 | 16,394 | 0 | 16,394 | |
| May 10 2018 | G | Genpact LTD | MANDL ALEX | Director | Grant | A | 0.00 | 3,961 | 0 | 39,911 | 36 K to 39.9 K (+11.02 %) |
| Apr 03 2018 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 7.07 | 6,360 | 44,965 | 6,360 | |
| Oct 03 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 3.76 | 12,225 | 45,966 | 12,225 | |
| Sep 18 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 0.00 | 41,270 | 0 | 41,270 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 3.85 | 72,256 | 278,186 | 72,256 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 5.45 | 5,496 | 29,953 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 5.71 | 5,324 | 30,400 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 6.55 | 4,598 | 30,117 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 7.90 | 3,793 | 29,965 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 8.00 | 3,743 | 29,944 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 8.38 | 3,559 | 29,824 | 0 | |
| Jun 13 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | D | 9.45 | 109,473 | 1,034,520 | 0 | |
| May 11 2017 | G | Genpact LTD | MANDL ALEX | Director | Grant | A | 0.00 | 4,700 | 0 | 35,950 | 31.3 K to 36 K (+15.04 %) |
| Apr 05 2017 | AH | R1 RCM INC. | MANDL ALEX | Director | Option Exercise | A | 3.08 | 14,016 | 43,169 | 14,016 | |
| Jan 04 2017 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 2.29 | 18,797 | 43,045 | 18,797 | |
| Oct 05 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 2.42 | 18,349 | 44,405 | 18,349 | |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.55 | 20,000 | 31,000 | 200,000 | 180 K to 200 K (+11.11 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.54 | 1,000 | 1,540 | 180,000 | 179 K to 180 K (+0.56 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.53 | 5,000 | 7,650 | 179,000 | 174 K to 179 K (+2.87 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.80 | 25,001 | 45,002 | 174,000 | 149 K to 174 K (+16.78 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.79 | 5,599 | 10,022 | 148,999 | 143.4 K to 149 K (+3.90 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.51 | 4,500 | 6,795 | 143,400 | 138.9 K to 143.4 K (+3.24 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.76 | 1,300 | 2,288 | 138,900 | 137.6 K to 138.9 K (+0.94 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.74 | 2,500 | 4,350 | 137,600 | 135.1 K to 137.6 K (+1.85 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.73 | 10,100 | 17,473 | 135,100 | 125 K to 135.1 K (+8.08 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.72 | 10,000 | 17,200 | 125,000 | 115 K to 125 K (+8.70 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.53 | 13,100 | 20,043 | 115,000 | 101.9 K to 115 K (+12.86 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.51 | 1,200 | 1,812 | 101,900 | 100.7 K to 101.9 K (+1.19 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.51 | 35,000 | 52,850 | 100,700 | 65.7 K to 100.7 K (+53.27 %) |
| Aug 11 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Buy | P | 1.51 | 65,700 | 99,207 | 65,700 | 0 to 65.7 K |
| Jul 06 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 2.00 | 20,513 | 41,026 | 20,513 | |
| May 04 2016 | G | Genpact LTD | MANDL ALEX | Director | Grant | A | 0.00 | 4,270 | 0 | 31,250 | 27 K to 31.3 K (+15.83 %) |
| Apr 05 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 2.53 | 16,064 | 40,642 | 16,064 | |
| Jan 06 2016 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 3.20 | 12,500 | 40,000 | 12,500 | |
| Oct 05 2015 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 2.50 | 16,168 | 40,420 | 16,168 | |
| Jul 06 2015 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 5.45 | 5,496 | 29,953 | 5,496 | |
| May 15 2015 | G | Genpact LTD | MANDL ALEX | Director | Grant | A | 0.00 | 5,224 | 0 | 26,980 | 21.8 K to 27 K (+24.01 %) |
| Apr 02 2015 | AH | Accretive Health, ... | MANDL ALEX | Director | Option Exercise | A | 5.71 | 5,324 | 30,400 | 5,324 |
Page: 1